However, the Goldman Sachs example shows us another ... Firms that succeed at corporate innovation are willing to move slowly to test every element of a business model before investing.
Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback